Under the random-effects model, the pooled OR of RASSF1A methylation in prostate cancer cases, compared to non-cancer controls, was 14.73 with 95%CI = 7.58–28.61(Table 2). The gene discussed is RASSF1; the disease is Familial prostate cancer.